What's Happening?
The Journal of the American College of Cardiology: Advances has retracted a study that claimed the ketogenic diet does not contribute to arterial plaque buildup. The study, published in April 2025, faced criticism for its selective data reporting and
small control groups. Co-authors Dave Feldman, a tech entrepreneur, and Nicholas Norwitz, a physician, requested the retraction after identifying anomalies in the data. Despite the retraction, Feldman and Norwitz continue to promote their keto-focused research, having released a new preprint based on the same dataset. Critics argue that the re-framing of the data is more advocacy than science, as other studies have linked the keto diet to increased cholesterol and heart disease risk.
Why It's Important?
The retraction of this study highlights the ongoing debate over the health impacts of the ketogenic diet, which is popular for weight loss. The controversy underscores the importance of rigorous scientific methods and transparency in health research. The keto diet's potential link to increased cholesterol and heart disease risk could influence public health guidelines and individual dietary choices. This development may also affect the credibility of researchers involved and the broader perception of diet-related health claims.
What's Next?
The retraction may prompt further scrutiny of studies related to the ketogenic diet and its health impacts. Researchers and health professionals might call for more comprehensive studies to clarify the diet's effects on cardiovascular health. The scientific community may also push for stricter peer-review processes to prevent similar issues in future publications. Public health organizations could update dietary recommendations based on emerging evidence.
